AMARIN CORP PLC\UK Amortization of Intangible Assets
AMARIN CORP PLC\UK (AMRN) reported Amortization of Intangible Assets of $1.27 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-07-29
- AMARIN CORP PLC\UK amortization of intangible assets for the quarter ending 2026-06-30 was $636.00K, a 12.64% decline year-over-year.
- AMARIN CORP PLC\UK amortization of intangible assets for the quarter ending 2026-03-31 was $637.00K, a 12.62% decline year-over-year.
- AMARIN CORP PLC\UK amortization of intangible assets for the quarter ending 2025-12-31 was $701.00K, a 3.84% decline year-over-year.
- AMARIN CORP PLC\UK amortization of intangible assets for the quarter ending 2025-09-30 was $866.00K, a 18.96% increase year-over-year.
- AMARIN CORP PLC\UK amortization of intangible assets for fiscal 2025 was $3.02M, a 3.74% increase from fiscal 2024.
- AMARIN CORP PLC\UK amortization of intangible assets for fiscal 2024 was $2.92M, a 3.92% increase from fiscal 2023.
- AMARIN CORP PLC\UK amortization of intangible assets for fiscal 2023 was $2.81M, a 10.22% increase from fiscal 2022.
- AMARIN CORP PLC\UK amortization of intangible assets for fiscal 2022 was $2.54M, a 12.11% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $636.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.27M 10-Q · filed 2026-07-29 | $1.97M derived: sum of 3 quarters · filed 2026-07-29 | $2.84M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $637.00K 10-Q · filed 2026-04-29 | $1.34M derived: sum of 2 quarters · filed 2026-04-29 | $2.20M derived: sum of 3 quarters · filed 2026-04-29 | $2.93M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $701.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.57M derived: sum of 2 quarters · filed 2026-03-02 | $2.29M derived: sum of 3 quarters · filed 2026-07-29 | $3.02M 10-K · filed 2026-03-02 |
| 2025-09-30 | $866.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.59M derived: sum of 2 quarters · filed 2026-07-29 | $2.32M 10-Q · filed 2025-10-29 | $3.05M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $728.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.46M 10-Q · filed 2026-07-29 | $2.19M derived: sum of 3 quarters · filed 2026-07-29 | $2.91M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $729.00K 10-Q · filed 2026-04-29 | $1.46M derived: sum of 2 quarters · filed 2026-04-29 | $2.19M derived: sum of 3 quarters · filed 2026-04-29 | $2.92M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $729.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.46M derived: sum of 2 quarters · filed 2026-03-02 | $2.19M derived: sum of 3 quarters · filed 2026-03-02 | $2.92M 10-K · filed 2026-03-02 |
| 2024-09-30 | $728.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.46M derived: sum of 2 quarters · filed 2025-10-29 | $2.19M 10-Q · filed 2025-10-29 | $2.89M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $729.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $1.46M 10-Q · filed 2025-07-30 | $2.16M derived: sum of 3 quarters · filed 2026-03-02 | $2.86M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $729.00K 10-Q · filed 2025-05-07 | $1.43M derived: sum of 2 quarters · filed 2026-03-02 | $2.13M derived: sum of 3 quarters · filed 2026-03-02 | $2.83M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $701.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.40M derived: sum of 2 quarters · filed 2026-03-02 | $2.10M derived: sum of 3 quarters · filed 2026-03-02 | $2.81M 10-K · filed 2026-03-02 |
| 2023-09-30 | $701.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $1.40M derived: sum of 2 quarters · filed 2024-10-30 | $2.10M 10-Q · filed 2024-10-30 | $2.74M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-06-30 | $701.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $1.40M 10-Q · filed 2024-07-31 | $2.04M derived: sum of 3 quarters · filed 2025-03-12 | $2.67M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-03-31 | $702.00K 10-Q · filed 2024-05-01 | $1.34M derived: sum of 2 quarters · filed 2025-03-12 | $1.97M derived: sum of 3 quarters · filed 2025-03-12 | $2.61M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | $636.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $1.27M derived: sum of 2 quarters · filed 2025-03-12 | $1.91M derived: sum of 3 quarters · filed 2025-03-12 | $2.54M 10-K · filed 2025-03-12 |
| 2022-09-30 | $636.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $1.27M derived: sum of 2 quarters · filed 2023-11-01 | $1.91M 10-Q · filed 2023-11-01 | $2.55M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $637.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $1.27M 10-Q · filed 2023-08-02 | $1.91M derived: sum of 3 quarters · filed 2024-02-29 | $2.55M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $636.00K 10-Q · filed 2023-05-03 | $1.27M derived: sum of 2 quarters · filed 2024-02-29 | $1.91M derived: sum of 3 quarters · filed 2024-02-29 | $2.54M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.27M derived: sum of 2 quarters · filed 2024-02-29 | $1.91M derived: sum of 3 quarters · filed 2024-02-29 | $2.27M 10-K · filed 2024-02-29 |
| 2021-09-30 | $636.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $1.27M derived: sum of 2 quarters · filed 2022-10-27 | $1.63M 10-Q · filed 2022-10-27 | $1.99M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $636.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $997.00K 10-Q · filed 2022-08-03 | $1.36M derived: sum of 3 quarters · filed 2023-03-01 | $1.72M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $361.00K 10-Q · filed 2022-05-04 | $721.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.08M derived: sum of 3 quarters · filed 2023-03-01 | $1.44M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $360.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $721.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.08M derived: sum of 3 quarters · filed 2023-03-01 | $1.44M 10-K · filed 2023-03-01 |
| 2020-09-30 | $361.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $721.00K derived: sum of 2 quarters · filed 2021-11-03 | $1.08M 10-Q · filed 2021-11-03 | $1.28M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $360.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $720.00K 10-Q · filed 2021-08-05 | $915.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.08M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $360.00K 10-Q · filed 2021-04-29 | $555.00K derived: sum of 2 quarters · filed 2022-03-01 | $716.00K derived: sum of 3 quarters · filed 2022-03-01 | $878.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $356.00K derived: sum of 2 quarters · filed 2022-03-01 | $518.00K derived: sum of 3 quarters · filed 2022-03-01 | $679.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $323.00K derived: sum of 2 quarters · filed 2020-11-05 | $484.00K 10-Q · filed 2020-11-05 | $646.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $323.00K 10-Q · filed 2020-08-04 | $485.00K derived: sum of 3 quarters · filed 2021-02-25 | $646.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $161.00K 10-Q · filed 2020-04-30 | $323.00K derived: sum of 2 quarters · filed 2021-02-25 | $484.00K derived: sum of 3 quarters · filed 2021-02-25 | $645.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $323.00K derived: sum of 2 quarters · filed 2021-02-25 | $484.00K derived: sum of 3 quarters · filed 2021-02-25 | $646.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $322.00K derived: sum of 2 quarters · filed 2019-11-05 | $484.00K 10-Q · filed 2019-11-05 | $645.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $323.00K 10-Q · filed 2019-07-31 | $484.00K derived: sum of 3 quarters · filed 2020-02-25 | $646.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $162.00K 10-Q · filed 2019-05-01 | $323.00K derived: sum of 2 quarters · filed 2020-02-25 | $485.00K derived: sum of 3 quarters · filed 2020-02-25 | $646.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $323.00K derived: sum of 2 quarters · filed 2020-02-25 | $484.00K derived: sum of 3 quarters · filed 2020-02-25 | $646.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $323.00K derived: sum of 2 quarters · filed 2018-11-01 | $485.00K 10-Q · filed 2018-11-01 | $646.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $323.00K 10-Q · filed 2018-08-01 | $484.00K derived: sum of 3 quarters · filed 2019-02-27 | $646.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $162.00K 10-Q · filed 2018-05-02 | $323.00K derived: sum of 2 quarters · filed 2019-02-27 | $485.00K derived: sum of 3 quarters · filed 2019-02-27 | $646.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $323.00K derived: sum of 2 quarters · filed 2019-02-27 | $484.00K derived: sum of 3 quarters · filed 2019-02-27 | $645.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $323.00K derived: sum of 2 quarters · filed 2017-11-01 | $484.00K 10-Q · filed 2017-11-01 | $646.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $322.00K 10-Q · filed 2017-08-02 | $484.00K derived: sum of 3 quarters · filed 2018-02-27 | $645.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $161.00K 10-Q · filed 2017-05-03 | $323.00K derived: sum of 2 quarters · filed 2018-02-27 | $484.00K derived: sum of 3 quarters · filed 2018-02-27 | $646.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $323.00K derived: sum of 2 quarters · filed 2018-02-27 | $485.00K derived: sum of 3 quarters · filed 2018-02-27 | $646.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $323.00K derived: sum of 2 quarters · filed 2016-11-03 | $484.00K 10-Q · filed 2016-11-03 | $646.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $323.00K 10-Q · filed 2016-08-04 | $485.00K derived: sum of 3 quarters · filed 2017-03-01 | $646.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $161.00K 10-Q · filed 2016-05-05 | $323.00K derived: sum of 2 quarters · filed 2017-03-01 | $484.00K derived: sum of 3 quarters · filed 2017-03-01 | $646.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $323.00K derived: sum of 2 quarters · filed 2017-03-01 | $485.00K derived: sum of 3 quarters · filed 2017-03-01 | $646.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $323.00K derived: sum of 2 quarters · filed 2015-11-04 | $484.00K 10-Q · filed 2015-11-04 | $645.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $323.00K 10-Q · filed 2015-08-06 | $484.00K derived: sum of 3 quarters · filed 2016-02-25 | $646.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $161.00K 10-Q · filed 2015-05-08 | $322.00K derived: sum of 2 quarters · filed 2016-02-25 | $484.00K derived: sum of 3 quarters · filed 2016-02-25 | $646.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $323.00K derived: sum of 2 quarters · filed 2016-02-25 | $485.00K derived: sum of 3 quarters · filed 2016-02-25 | $646.00K 10-K · filed 2016-02-25 |
| 2013-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $324.00K derived: sum of 2 quarters · filed 2014-11-06 | $485.00K 10-Q · filed 2014-11-06 | $646.00K derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $323.00K 10-Q · filed 2014-08-07 | $484.00K derived: sum of 3 quarters · filed 2015-03-03 | |
| 2013-03-31 | $161.00K 10-Q · filed 2014-05-09 | $322.00K derived: sum of 2 quarters · filed 2015-03-03 | ||
| 2012-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $269.00K 10-K · filed 2015-03-03 | ||
| 2012-09-30 | $108.00K 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |